Amylyx Pharmaceuticals
AMLX | NASDAQ
$27.80
-$2.49 (-8.22%)
At close: Nov 16, 2026, 4:00 PM ET
$27.67
-$0.13 (-0.47%)
After-hours:
Nov 16, 2026, 7:30 PM ET
Amylyx Pharmaceuticals Statistics
Key statistics explainedMarket Data
$3.57B
$2.81B
-0.21
2.11M
118.94M
27.44%
N/A
NASDAQ
US03237H1014
Price Performance
5.5%
29.7%
116.2%
130.1%
98.9%
130.3%
N/A
5.5%
119.1%
N/A
11.2%
Valuation
-19.58
N/A
-0.91
9.05
N/A
68.10
4.74
-27.49
-22.17
-25.50
N/A
-17.43
-17.46
-21.62
-5.1%
-3.6%
-4.5%
Financial Health
$768.13M
$4.94M
$768.13M
$786.8M
26.81
26.81
0.01
-0.03
-0.04
-26.28
0.00
69.58
4
Margins & Profitability
0.0%
0.0%
0.0%
0.0%
N/A
N/A
0.0%
-24.0%
Returns
-20.7%
-41.5%
-23.2%
-23.2%
-20.7%
Historical Growth (CAGR)
-150.5%
-30.1%
N/A
51.1%
9.5%
N/A
-13.6%
-3.4%
N/A
Analyst Forecasts
Buy
6
70.2%
N/A
Mar 2, 2027
-$0.36
20.0%
$12K
N/A
Fair Value Estimates
N/A
N/A
N/A
N/A
$52.00
87.1%
Cash Flow
$-129.88M
$-130.02M
$-161.22M
-$1.09
-$1.09
0.0%
Income Statement
$0
$-108K
$-175.74M
$-160.97M
$-163.2M
-$1.42
N/A
$-1.2M
136
Add to Watchlist
Select watchlists to add or remove AMLX